Results for tag: "Sabril"

The Sabril market is a subset of the Central Nervous System (CNS) drugs market. Sabril is a brand name for vigabatrin, an antiepileptic drug used to treat certain types of seizures in adults and children. It is also used to treat infantile spasms in children. Sabril works by increasing the amount of gamma-aminobutyric acid (GABA) in the brain, which helps to reduce the number of seizures. The CNS drugs market is a rapidly growing market, driven by the increasing prevalence of neurological disorders such as epilepsy, Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. The market is expected to continue to grow in the coming years, driven by the increasing demand for CNS drugs. Some of the major companies in the Sabril market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Johnson & Johnson. These companies are involved in the development, manufacture, and marketing of Sabril and other CNS drugs. Show Less Read more